Biostar Files PRC Patent Application For Oleanolic Acid Injection

(RTTNews) - Biostar Pharmaceuticals, Inc. (BSPM), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products, said it has filed PRC national invention and creation patent for the pharmaceutical and preparation method of its new developed product, Oleanolic Acid Injection, which is designed to treat Hepatitis B and liver cancer.

The application passed the preliminary examination of the PRC State Intellectual Property Bureau and was accepted for review.

The filed patent is for the pharmaceutical and preparation method developed by the company's R&D team, together with the experts of Shaanxi University of Chinese Medicine.

It is one of drug development efforts by the company in combating Hepatitis B and liver cancer and is currently under pharmacological research.